Zobrazeno 1 - 10
of 163
pro vyhledávání: '"Aliya Qayyum"'
42 The role of tissue stiffness in predicting the immunotherapy response in hepatocellular carcinoma
Autor:
Lianchun Xiao, Ahmed Kaseb, Sunyoung Lee, Asif Rashid, Elshad Hasanov, Betul Gok Yavuz, Yehia Mohamed, Aliya Qayyum
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/72fdcb4c7705403ca45c0f5bea76d7d8
Autor:
Aliya Qayyum, Ken-Pin Hwang, Jason Stafford, Anuj Verma, Dipen M. Maru, Subramanya Sandesh, Jia Sun, Roberto Carmagnani Pestana, Rony Avritscher, Manal M. Hassan, Hesham Amin, Asif Rashid, Ignacio I. Wistuba, Richard L. Ehman, Jingfei Ma, Ahmed O. Kaseb
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-6 (2019)
Abstract Background Currently, there are no imaging predictors of immunotherapy outcome in hepatocellular carcinoma (HCC). The study aim was to determine if stiffness changes measured by magnetic resonance elastography (MRE) can be a predictor of imm
Externí odkaz:
https://doaj.org/article/73309b6a517145a2968535497c6f6d9f
Autor:
Ahmed W. Moawad, David Fuentes, Ahmed M. Khalaf, Katherine J. Blair, Janio Szklaruk, Aliya Qayyum, John D. Hazle, Khaled M. Elsayes
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Hepatocellular carcinoma (HCC) is the most common liver malignancy and the leading cause of death in patients with cirrhosis. Various treatments for HCC are available, including transarterial chemoembolization (TACE), which is the commone
Externí odkaz:
https://doaj.org/article/d18053e4a9024b0cabf0dc8571ad589d
Autor:
Tatsuyuki Tonan, Kiminori Fujimoto, Aliya Qayyum, Takumi Kawaguchi, Atsushi Kawaguchi, Osamu Nakashima, Koji Okuda, Naofumi Hayabuchi, Michio Sata
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e33868 (2012)
OBJECTIVE: To investigate the usefulness of single-shot spin-echo echo-planar imaging (SSEPI) sequence for quantifying mild degree of hepatic iron stores in patients with viral hepatitis. METHODS: This retrospective study included 34 patients with ch
Externí odkaz:
https://doaj.org/article/d0dae60e7aa64dff8d9643612c0651cc
Autor:
Tatsuyuki Tonan, Kiminori Fujimoto, Aliya Qayyum, Takumi Kawaguchi, Atsushi Kawaguchi, Osamu Nakashima, Koji Okuda, Naofumi Hayabuchi, Michio Sata
Publikováno v:
PLoS ONE, Vol 7, Iss 7 (2012)
Externí odkaz:
https://doaj.org/article/26eb2ab85b074971856ab99d7d66c204
Autor:
Ahmed Omar Kaseb, Elshad Hasanov, Hop Sanderson Tran Cao, Lianchun Xiao, Jean-Nicolas Vauthey, Sunyoung S Lee, Betul Gok Yavuz, Yehia I Mohamed, Aliya Qayyum, Sonali Jindal, Fei Duan, Sreyashi Basu, Shalini S Yadav, Courtney Nicholas, Jing Jing Sun, Kanwal Pratap Singh Raghav, Asif Rashid, Kristen Carter, Yun Shin Chun, Ching-Wei David Tzeng, Divya Sakamuri, Li Xu, Ryan Sun, Vittorio Cristini, Laura Beretta, James C Yao, Robert A Wolff, James Patrick Allison, Padmanee Sharma
Publikováno v:
Lancet Gastroenterol Hepatol
Kaseb, A O, Hasanov, E, Cao, H S T, Xiao, L, Vauthey, J N, Lee, S S, Yavuz, B G, Mohamed, Y I, Qayyum, A, Jindal, S, Duan, F, Basu, S, Yadav, S S, Nicholas, C, Sun, J J, Singh Raghav, K P, Rashid, A, Carter, K, Chun, Y S, Tzeng, C W D, Sakamuri, D, Xu, L, Sun, R, Cristini, V, Beretta, L, Yao, J C, Wolff, R A, Allison, J P & Sharma, P 2022, ' Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma : a randomised, open-label, phase 2 trial ', The Lancet Gastroenterology and Hepatology, vol. 7, no. 3, pp. 208-218 . https://doi.org/10.1016/S2468-1253(21)00427-1
Kaseb, A O, Hasanov, E, Cao, H S T, Xiao, L, Vauthey, J N, Lee, S S, Yavuz, B G, Mohamed, Y I, Qayyum, A, Jindal, S, Duan, F, Basu, S, Yadav, S S, Nicholas, C, Sun, J J, Singh Raghav, K P, Rashid, A, Carter, K, Chun, Y S, Tzeng, C W D, Sakamuri, D, Xu, L, Sun, R, Cristini, V, Beretta, L, Yao, J C, Wolff, R A, Allison, J P & Sharma, P 2022, ' Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma : a randomised, open-label, phase 2 trial ', The Lancet Gastroenterology and Hepatology, vol. 7, no. 3, pp. 208-218 . https://doi.org/10.1016/S2468-1253(21)00427-1
Background: Hepatocellular carcinoma has high recurrence rates after surgery; however, there are no approved standard-of-care neoadjuvant or adjuvant therapies. Immunotherapy has been shown to improve survival in advanced hepatocellular carcinoma; we
Autor:
Yehia I. Mohamed, Dan G. Duda, Muhammad O. Awiwi, Sunyoung S. Lee, Lina Altameemi, Lianchun Xiao, Jeffrey S. Morris, Robert A. Wolff, Khaled M. Elsayes, Rikita I. Hatia, Aliya Qayyum, Shadi M. Chamseddine, Asif Rashid, James C. Yao, Armeen Mahvash, Manal M. Hassan, Hesham M. Amin, Ahmed Omar Kaseb
Publikováno v:
Oncotarget. 13
Hepatocellular carcinoma (HCC) has limited systemic therapy options when discovered at an advanced stage. Thus, there is a need for accessible and minimally invasive biomarkers of response to guide the selection of patients for treatment. This study
Autor:
Aliya Qayyum, Yusuf Karakas, Manal M. Hassan, Hesham M. Amin, Ahmed Kaseb, Sahin Lacin, Yehia I. Mohamed, Suayib Yalcin, Asif Rashid, Lianchun Xiao, Jeffrey S. Morris
Publikováno v:
Journal of Hepatocellular Carcinoma. 7:143-153
Background The Child-Turcotte-Pugh score (CTP) is the most commonly used tool to assess hepatic reserve and predict survival in hepatocellular cancer (HCC). The CTP stratification accuracy has been questioned and attempts have been made to improve th
Autor:
Aliya Qayyum
Publikováno v:
The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases ISBN: 9789811900624
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1d25ea438d18c02baee2eb4a94b3977
https://doi.org/10.1007/978-981-19-0063-1_14
https://doi.org/10.1007/978-981-19-0063-1_14
Autor:
Jingfei Ma, Asif Rashid, Subramanya Sandesh, Anuj Verma, Jia Sun, Ignacio I. Wistuba, Jason Stafford, Aliya Qayyum, Ken Pin Hwang, Rony Avritscher, Richard L. Ehman, Ahmed Kaseb, Manal M. Hassan, Roberto Carmagnani Pestana, Hesham M. Amin, Dipen M. Maru
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-6 (2019)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Background Currently, there are no imaging predictors of immunotherapy outcome in hepatocellular carcinoma (HCC). The study aim was to determine if stiffness changes measured by magnetic resonance elastography (MRE) can be a predictor of immunotherap